COMMUNIQUÉS West-GlobeNewswire

SELLAS Life Sciences Presents Interim Phase 1 Clinical Data of Galinpepimut-S (GPS) in Combination with Nivolumab to Treat Wilms Tumor 1 Positive (WT1+) Ovarian Cancer Patients at ASCO 2018

04/06/2018 - 14:45

1-year progression-free survival (PFS) rate of 70% with induction of serum levels of WT1 Antigen-Specific Immunoglobulin G (IgG) in 86% of patients treated with GPS in combination with programmed cell death protein-1 ( [...]

Marrone Bio Innovations Launches New CG Brand of Highly Effective Biological Solutions for Crop Protection in Cannabis and Home Gardens

04/06/2018 - 14:31

Smaller package sizes of Regalia® CG, Grandevo® CG and Venerate® CG address the most economically damaging pests and diseases in cannabis production and for home gardeners DAVIS, Calif., June 04, 2018 (GLOBE NEWSWIRE [...]

Progenics Pharmaceuticals Announces Presentation of Updated Data from the Pivotal Trial of AZEDRA® (iobenguane I 131) at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting

04/06/2018 - 14:30

NEW YORK, June 04, 2018 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX), an oncology company developing innovative medicines and other products for targeting and treating cancer, announced updated [...]

New Interim Phase 2a Study Results Demonstrate Broad Clinical Activity of Portola Pharmaceuticals’ Oral SYK/JAK Inhibitor Cerdulatinib

04/06/2018 - 14:30

– Differentiated SYK-JAK Inhibitor Shows Efficacy in Patients with Heavily Pre-Treated B- and T-Cell Malignancies – – New Signal in AITL; Five Complete Responses for a Complete Response Rate of 71 Percent – – Data to be [...]

Natus Medical Board of Directors Mails Letter to Shareholders

04/06/2018 - 14:30

Recommends Voting on the WHITE Proxy Card FOR the Election of Doris Engibous and Robert Weiss Shareholders Should Not Vote for Removal of Chairman Robert Gunst Illustrates Highly-Qualified and Committed Directors with [...]

Interpace Diagnostics to Attend and Present at the 8th Annual LD Micro Invitational Conference

04/06/2018 - 14:30

PARSIPPANY, N.J., June 04, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company that provides clinically [...]

Oxford Immunotec Announces Data Presentations for T-SPOT®.CMV Test at the 2018 American Transplant Congress

04/06/2018 - 14:30

OXFORD, United Kingdom and MARLBOROUGH, Mass., June 04, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced that data from studies utilizing the [...]

Daxor Corporation Initiates Study with Virginia Commonwealth University to Measure Improvement of Survival Rates Following Burn Surgery As A Result of Optimized Blood Volume Assessment

04/06/2018 - 14:30

NEW YORK, June 04, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) , an innovative medical instrumentation and biotechnology company focused on blood volume measurement today announces the initiation of an [...]

Sarepta Therapeutics Appoints Louise Rodino-Klapac, Ph.D. to Lead Newly Created Gene Therapy Business Unit

04/06/2018 - 14:30

-- Dr. Rodino-Klapac, a National Institutes of Health Fellow, is a pioneer in the advancement of gene therapy to treat human disease, whose discoveries have advanced six gene therapy programs from bench to human [...]

Cesca Therapeutics Announces Reduction in Operating Expenses

04/06/2018 - 14:30

RANCHO CORDOVA, Calif., June 04, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca” or the “Company”) (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies [...]

Viveve Announces Settlement of Patent Infringement Litigation with Thermi

04/06/2018 - 14:28

ENGLEWOOD, Colo., June 04, 2018 (GLOBE NEWSWIRE) -- Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that is has reached a settlement to resolve the [...]

Evolus to Present at the Jefferies 2018 Global Healthcare Conference

04/06/2018 - 14:01

IRVINE, Calif., June 04, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (“Evolus”) (NASDAQ:EOLS), a premiere aesthetics company focused on delivering advanced aesthetic procedures and treatments to physicians and consumers, [...]

Results from Phase 1 Study of CB-839 in Combination with Capecitabine in Advanced Solid Tumors to be Presented at the 2018 American Society of Clinical Oncology (ASCO)

04/06/2018 - 14:01

Phase 2 to Continue Enrolling Colorectal Cancer Patients with PIK3CA Mutation SOUTH SAN FRANCISCO, Calif., June 04, 2018 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical stage biotechnology [...]

DBV Technologies : Correctif - Assemblée Générale Mixte du 22 juin 2018 - Modalités de mise à disposition des documents préparatoires à l'Assemblée

04/06/2018 - 14:00

Montrouge, France, le 1 juin (07h30 CEST) 2018 Assemblée Générale Mixte du 22 juin 2018 Modalités de mise à disposition des documents préparatoires à l'Assemblée DBV Technologies (Euronext : DBV - ISIN : FR0010417345 - [...]

Athenex Names Christina Wang as Vice President of Clinical Operations and Corporate Development, Asia Pacific

04/06/2018 - 14:00

BUFFALO, N.Y., June 04, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq:ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]

Versartis Enters into Merger Agreement with Aravive Biologics to Form a Clinical-Stage Biopharmaceutical Company Advancing Innovative Oncology Therapeutics

04/06/2018 - 14:00

- Tolerability and proof-of-mechanism for lead candidate AVB-S6-500, a novel GAS6-AXL pathway inhibitor, established in ongoing Phase 1 clinical study - Multi-study clinical development program in combination with [...]

Checkpoint Therapeutics to Participate in June Investor Conferences

04/06/2018 - 14:00

NEW YORK, June 04, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ:CKPT), a clinical-stage, immuno-oncology biopharmaceutical company focused on the acquisition, development and [...]

Soleno Therapeutics To Present Corporate Update at the BIO International Convention

04/06/2018 - 14:00

REDWOOD CITY, Calif., June 04, 2018 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ:SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, [...]

Retrophin Announces Pivotal Phase 3 FORT Study of Fosmetpantotenate in PKAN Opens Enrollment to Pediatric Patients

04/06/2018 - 14:00

Independent Data Monitoring Committee’s (DMC) review of available safety data supports continuing with study as planned; FORT Study now open to pediatric patients aged 6 to 17 Top-line data anticipated in the second [...]